FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048119879> ?p ?o ?g. }

• W2048119879 endingPage "2361" @default.
• W2048119879 startingPage "2355" @default.
• W2048119879 abstract "The aim of our study was to examine whether an extensive surveillance protocol will promote early diagnosis and improved survival in patients with de novo cancer following liver transplantation (LT). Of 779 consecutive LT recipients, 96 (12.3%) developed 105 malignancies. The cumulative risk for the development of de novo cancer was 10%, 24%, 32% and 42% at 5, 10, 15 and 20 years after LT, respectively. The most frequent tumor types were skin (17%), lung (16%), oropharyngeal (11%) and prostate cancer (11%). The overall standard incidence ratio as compared to that of the general population was 1.9 (95% CI: 1.5–2.3). The median survival of patients with de novo non-skin cancers was 3.1 years after diagnosis. Only patients with skin cancers and solid tumors, diagnosed at early stages, showed an excellent outcome. After introducing an intensified surveillance protocol, the detection rate of de novo cancers increased from 4.9% to 13% and more de novo malignancies were diagnosed in earlier stages. For non-skin cancers, the median tumor-related survival significantly improved from 1.2 to 3.3 years as well as the median overall survival post-LT. This study indicates that an extensive tumor surveillance program is highly recommendable in LT recipients. The aim of our study was to examine whether an extensive surveillance protocol will promote early diagnosis and improved survival in patients with de novo cancer following liver transplantation (LT). Of 779 consecutive LT recipients, 96 (12.3%) developed 105 malignancies. The cumulative risk for the development of de novo cancer was 10%, 24%, 32% and 42% at 5, 10, 15 and 20 years after LT, respectively. The most frequent tumor types were skin (17%), lung (16%), oropharyngeal (11%) and prostate cancer (11%). The overall standard incidence ratio as compared to that of the general population was 1.9 (95% CI: 1.5–2.3). The median survival of patients with de novo non-skin cancers was 3.1 years after diagnosis. Only patients with skin cancers and solid tumors, diagnosed at early stages, showed an excellent outcome. After introducing an intensified surveillance protocol, the detection rate of de novo cancers increased from 4.9% to 13% and more de novo malignancies were diagnosed in earlier stages. For non-skin cancers, the median tumor-related survival significantly improved from 1.2 to 3.3 years as well as the median overall survival post-LT. This study indicates that an extensive tumor surveillance program is highly recommendable in LT recipients." @default.
• W2048119879 created "2016-06-24" @default.
• W2048119879 creator A5004900644 @default.
• W2048119879 creator A5015322768 @default.
• W2048119879 creator A5019003637 @default.
• W2048119879 creator A5021321712 @default.
• W2048119879 creator A5048869932 @default.
• W2048119879 creator A5053268191 @default.
• W2048119879 creator A5081275907 @default.
• W2048119879 creator A5087598341 @default.
• W2048119879 date "2009-10-01" @default.
• W2048119879 modified "2023-10-14" @default.
• W2048119879 title "Extensive Surveillance Promotes Early Diagnosis and Improved Survival of De Novo Malignancies in Liver Transplant Recipients" @default.
• W2048119879 cites W141770798 @default.
• W2048119879 cites W1969333586 @default.
• W2048119879 cites W1989312090 @default.
• W2048119879 cites W1996883206 @default.
• W2048119879 cites W2011848710 @default.
• W2048119879 cites W2017912874 @default.
• W2048119879 cites W2019214729 @default.
• W2048119879 cites W2025901428 @default.
• W2048119879 cites W2026568633 @default.
• W2048119879 cites W2027286769 @default.
• W2048119879 cites W2031827337 @default.
• W2048119879 cites W2053758773 @default.
• W2048119879 cites W2065754270 @default.
• W2048119879 cites W2071788318 @default.
• W2048119879 cites W2091572835 @default.
• W2048119879 cites W2094500109 @default.
• W2048119879 cites W2109569951 @default.
• W2048119879 cites W2109810752 @default.
• W2048119879 cites W2133617047 @default.
• W2048119879 cites W2133676969 @default.
• W2048119879 cites W2135061264 @default.
• W2048119879 cites W2136128960 @default.
• W2048119879 cites W2157836255 @default.
• W2048119879 cites W2335592377 @default.
• W2048119879 cites W2566863750 @default.
• W2048119879 doi "https://doi.org/10.1111/j.1600-6143.2009.02766.x" @default.
• W2048119879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19663894" @default.
• W2048119879 hasPublicationYear "2009" @default.
• W2048119879 type Work @default.
• W2048119879 sameAs 2048119879 @default.
• W2048119879 citedByCount "114" @default.
• W2048119879 countsByYear W20481198792012 @default.
• W2048119879 countsByYear W20481198792013 @default.
• W2048119879 countsByYear W20481198792014 @default.
• W2048119879 countsByYear W20481198792015 @default.
• W2048119879 countsByYear W20481198792016 @default.
• W2048119879 countsByYear W20481198792017 @default.
• W2048119879 countsByYear W20481198792018 @default.
• W2048119879 countsByYear W20481198792019 @default.
• W2048119879 countsByYear W20481198792020 @default.
• W2048119879 countsByYear W20481198792021 @default.
• W2048119879 countsByYear W20481198792022 @default.
• W2048119879 countsByYear W20481198792023 @default.
• W2048119879 crossrefType "journal-article" @default.
• W2048119879 hasAuthorship W2048119879A5004900644 @default.
• W2048119879 hasAuthorship W2048119879A5015322768 @default.
• W2048119879 hasAuthorship W2048119879A5019003637 @default.
• W2048119879 hasAuthorship W2048119879A5021321712 @default.
• W2048119879 hasAuthorship W2048119879A5048869932 @default.
• W2048119879 hasAuthorship W2048119879A5053268191 @default.
• W2048119879 hasAuthorship W2048119879A5081275907 @default.
• W2048119879 hasAuthorship W2048119879A5087598341 @default.
• W2048119879 hasBestOaLocation W20481198791 @default.
• W2048119879 hasConcept C120665830 @default.
• W2048119879 hasConcept C121332964 @default.
• W2048119879 hasConcept C121608353 @default.
• W2048119879 hasConcept C126322002 @default.
• W2048119879 hasConcept C143998085 @default.
• W2048119879 hasConcept C2776231280 @default.
• W2048119879 hasConcept C2777789703 @default.
• W2048119879 hasConcept C2779609443 @default.
• W2048119879 hasConcept C2908647359 @default.
• W2048119879 hasConcept C2911091166 @default.
• W2048119879 hasConcept C61511704 @default.
• W2048119879 hasConcept C71924100 @default.
• W2048119879 hasConcept C88879693 @default.
• W2048119879 hasConcept C90924648 @default.
• W2048119879 hasConcept C99454951 @default.
• W2048119879 hasConceptScore W2048119879C120665830 @default.
• W2048119879 hasConceptScore W2048119879C121332964 @default.
• W2048119879 hasConceptScore W2048119879C121608353 @default.
• W2048119879 hasConceptScore W2048119879C126322002 @default.
• W2048119879 hasConceptScore W2048119879C143998085 @default.
• W2048119879 hasConceptScore W2048119879C2776231280 @default.
• W2048119879 hasConceptScore W2048119879C2777789703 @default.
• W2048119879 hasConceptScore W2048119879C2779609443 @default.
• W2048119879 hasConceptScore W2048119879C2908647359 @default.
• W2048119879 hasConceptScore W2048119879C2911091166 @default.
• W2048119879 hasConceptScore W2048119879C61511704 @default.
• W2048119879 hasConceptScore W2048119879C71924100 @default.
• W2048119879 hasConceptScore W2048119879C88879693 @default.
• W2048119879 hasConceptScore W2048119879C90924648 @default.
• W2048119879 hasConceptScore W2048119879C99454951 @default.
• W2048119879 hasIssue "10" @default.
• W2048119879 hasLocation W20481198791 @default.

• next